HRQoL in Patients With Solid Tumors Treated With Hadrontherapy
The Quality of Life of patients treated with hadrontherapy is still limited. Two cohorts are established, they will be receiving specific standardized questionnaires to be evalutaed in their results.
| Condition(s) | Head and Neck Cancer, Skull Base--Cancer, Brain Cancer |
|---|---|
| Status | Recruiting |
| Study type | Observational |
| Summary | The Quality of Life of patients treated with hadrontherapy is still limited. Two cohorts are established, they will be receiving specific standardized questionnaires to be evalutaed in their results. |
| Who can participate | Cohort A ("survivors"): Inclusion Criteria * Patients with at least a follow up of 5 years with head and neck, skull base and brain tumors and no evidence of progressive disease. * The patient is able to give consent Exclusion Criteria: * Re-irradiation. * Second tumor. * Known cases of any psychiatric and neurological diseases leading to disability (eg, manic disorder, schizophrenia etc..), which could impair compilation of questionnaires or affect quality of life. Cohort B: Inclusion Criteria: * Histological and/or radiological diagnosis of head and neck tumors * Patients candidate for curative intent hadrontherapy * Patients ≥ 18 years of age * The patient is able to give consent Exclusion criteria: * Re-irradiation. * Second tumor * Known cases of any psychiatric and neurological disea |
| Ages | 18 Years |
| Sex | All |
| Lead sponsor | CNAO National Center of Oncological Hadrontherapy |
| Locations | Pavia, Pv, Italy |
| Start date | 2023-03-27 |
| NCT ID | NCT05947149 |
| Official listing | https://clinicaltrials.gov/study/NCT05947149 |